Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M500817200 on April 11, 2005

J. Biol. Chem., Vol. 280, Issue 25, 23771-23777, June 24, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
280/25/23771    most recent
M500817200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barbier, J.-R.
Right arrow Articles by Willick, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barbier, J.-R.
Right arrow Articles by Willick, G. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Backbone-methylated Analogues of the Principle Receptor Binding Region of Human Parathyroid Hormone

EVIDENCE FOR BINDING TO BOTH THE N-TERMINAL EXTRACELLULAR DOMAIN AND EXTRACELLULAR LOOP REGION*{boxs}

Jean-René Barbier{ddagger}, Thomas J. Gardella§, Thomas Dean§, Susanne MacLean{ddagger}, Zhanna Potetinova{ddagger}, James F. Whitfield{ddagger}, and Gordon E. Willick{ddagger}

From the {ddagger}Institute for Biological Sciences, National Research Council, Ottawa, Ontario K1A 0R6 Canada and §Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114

We have used backbone N-methylations of parathyroid hormone (PTH) to study the role of these NH groups in the C-terminal amphiphilic {alpha}-helix of PTH (1–31) in binding to and activating the PTH receptor (P1R). The circular dichroism (CD) spectra indicated the structure of the C-terminal {alpha}-helix was locally disrupted around the methylation site. The CD spectra differences were explained by assuming a helix disruption for four residues on each side of the site of methylation and taking into account the known dependence of CD on the length of an {alpha}-helix. Binding and adenylyl cyclase-stimulating data showed that outside of the {alpha}-helix, methylation of residues Asp30 and Val31 had little effect on structure or activities. Within the {alpha}-helix, disruption of the structure was associated with increased loss of activity, but for specific residues Val21, Leu24, Arg25, and Leu28 there was a dramatic loss of activities, thus suggesting a more direct role of these NH groups in correct P1R binding and activation. Activity analyses with P1R-delNT, a mutant with its long N-terminal region deleted, gave a different pattern of effects and implicated Ser17, Trp23, and Lys26 as important for its PTH activation. These two groups of residues are located on opposite sides of the helix. These results are compatible with the C-terminal helix binding to both the N-terminal segment and also to the looped-out extracellular region. These data thus provide direct evidence for important roles of the C-terminal domain of PTH in determining high affinity binding and activation of the P1R receptor.


Received for publication, January 24, 2005 , and in revised form, April 8, 2005.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{boxs} The on-line version of this article (available at http://www.jbc.org) contains supplemental Table I.

To whom correspondence should be addressed: Institute for Biological Sciences, National Research Council, Ottawa, ON, K1A 0R6, Canada. Tel.: 613-990-0852; Fax: 613-952-9092; E-mail: gordon.willick{at}nrc.ca.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
IBMS BoneKEyHome page
T. J. Gardella
Mimetic Ligands for the PTHR1: Approaches, Developments, and Considerations
IBMS BoneKEy, February 1, 2009; 6(2): 71 - 85.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Assil-Kishawi, T. A. Samra, D. F. Mierke, and A. B. Abou-Samra
Residue 17 of Sauvagine Cross-links to the First Transmembrane Domain of Corticotropin-releasing Factor Receptor 1 (CRFR1)
J. Biol. Chem., December 19, 2008; 283(51): 35644 - 35651.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Dean, A. Khatri, Z. Potetinova, G. E. Willick, and T. J. Gardella
Role of Amino Acid Side Chains in Region 17-31 of Parathyroid Hormone (PTH) in Binding to the PTH Receptor
J. Biol. Chem., October 27, 2006; 281(43): 32485 - 32495.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement